|
|
|
|
| LEADER |
01573nmm a2200397 u 4500 |
| 001 |
EB001961058 |
| 003 |
EBX01000000000000001123960 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
210421 ||| eng |
| 100 |
1 |
|
|a Klenerman, Paul
|
| 245 |
0 |
0 |
|a The immune system response to the SARS-CoV-2 virus
|h Elektronische Ressource
|b March 2021 update
|c an interview with Paul Klenerman
|
| 260 |
|
|
|a London
|b Henry Stewart Talks
|c 2021, 2021
|
| 300 |
|
|
|a 1 streaming audio file (20 min.))
|
| 505 |
0 |
|
|a Contents: Biology of the SARS-CoV-2 mutations -- T cell response to vaccination -- The long-term health effects from a SARS-CoV-2 infection -- Current and future treatments for COVID-19 -- Future work in the field
|
| 653 |
|
|
|a Vaccination
|
| 653 |
|
|
|a COVID-19 Vaccines
|
| 653 |
|
|
|a Immunity
|
| 653 |
|
|
|a T-Lymphocytes
|
| 653 |
|
|
|a COVID-19 (Disease) / Treatment
|
| 653 |
|
|
|a Immune System
|
| 653 |
|
|
|a COVID-19 / immunology
|
| 653 |
|
|
|a COVID-19 (Disease) / Research
|
| 653 |
|
|
|a Mutation
|
| 653 |
|
|
|a COVID-19 Pandemic, 2020-
|
| 653 |
|
|
|a SARS-CoV-2 / virology
|
| 653 |
|
|
|a COVID-19 / pathology
|
| 653 |
|
|
|a COVID-19 / drug therapy
|
| 653 |
|
|
|a Immune response
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b HST
|a Henry Stewart Talks
|
| 490 |
0 |
|
|a Research and clinical interviews
|
| 500 |
|
|
|a Audio interview. - Title from title frames. - Mode of access: World Wide Web
|
| 856 |
4 |
2 |
|u https://hstalks.com/bs/p/1060
|3 Series
|
| 856 |
4 |
0 |
|u https://hstalks.com/bs/4606
|x Verlag
|z Streaming video file
|
| 082 |
0 |
|
|a 570
|